AI-assisted Gastroscopic Varicose Vein Diagnosis
A Prospective Multicenter Study of AI-assisted Gastroscopic Varices Diagnosis
1 other identifier
observational
793
1 country
1
Brief Summary
Validation of the accuracy of AI in assisting gastroscopic varices diagnosis through a prospective multicenter study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 13, 2022
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedStudy Start
First participant enrolled
April 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2022
CompletedMarch 24, 2022
March 1, 2022
6 months
February 13, 2022
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The accuracy of artificial intelligence
Accuracy of AI in the description and treatment recommendations of esophagogastric varices diagnosis and endoscopic findings (form, color, red sign, hemorrhagic sign, and mucosal findings).
2022/12/25
Eligibility Criteria
Patients with cirrhosis who visited each center of the study from February 2022 to December 2022.
You may qualify if:
- Male or female aged 18 years or above;
- Gastroscopy and related examinations are required to further clarify the characteristics of digestive tract diseases;
- Patients with liver cirrhosis who have signs or symptoms of portal hypertension and have clinical indications for endoscopic screening for varicose veins.
- Able to read, understand and sign the informed consent;
- The researcher believes that the subjects can understand the process of the clinical study, are willing and able to complete all the research procedures and follow-up visits, and cooperate with the research procedures.
You may not qualify if:
- \) Pregnant or breastfeeding women; 2) Patients with a history of esophagogastric surgery; 3) Patients who have received interventional or endoscopic treatment in the past; 4) The patient has high-risk diseases or other special conditions that are not suitable for participating in clinical trials; 5) The patient is clearly diagnosed with esophageal or gastric diverticulum, polyps, cancer and other diseases that may affect the observation of varicose veins; 6) The patient's endoscopic video cannot reach a consensus diagnosis and treatment opinion after being watched by three experts.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
February 13, 2022
First Posted
March 24, 2022
Study Start
April 25, 2022
Primary Completion
October 25, 2022
Study Completion
December 25, 2022
Last Updated
March 24, 2022
Record last verified: 2022-03